Recent Updates
Recently added Catalysts
PEN

Penumbra, Inc. to Present at the BMO Prescriptions for Success Healthcare Conference Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BMO Prescriptions for Success Healthcare...

Key Takeaway: ALAMEDA, Calif. , Nov. 29, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the BMO Prescriptions for Success Healthcare Conference in New York, NY on Wednesday, December 12 , 2018. A webcast of the presentation

Full Press Release Details

ALAMEDA, Calif. , Nov. 29, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the BMO Prescriptions for Success Healthcare Conference in New York, NY on Wednesday, December 12 , 2018.
Event: BMO Prescriptions for Success Healthcare Conference
Date: Wednesday, December 12, 2018
Time: 10:40am ET / 7:40am PT
A webcast of the presentation will be available by visiting the investors section of the company's website at www.penumbrainc.com . The webcast will be available on the company's website for two weeks following the event.
Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States , most of Europe , Canada and Australia , and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com .
Investor Relations
Penumbra, Inc. 510-995-2461
[email protected]
Source: Penumbra, Inc.
SOURCE Penumbra, Inc.

Related Links

21 %

Last updated: Nov 29, 2018